Specific Survey of Norditropin® in Achondroplasia: Survey for Long-term Application
Specific Survey of Norditropin® in Achondroplasia: Survey for Long-term Application
This study is conducted in Japan. The aim of this study is to assess the incidence rate of adverse drug reactions (ADRs) when using somatropin (Norditropin®) for treatment of for achondroplasia without epiphyseal line closure under normal clinical practice conditions.
Inclusion Criteria: